Integrated Post-Translational Modification (PTM) Proteomics Reveals Early Redox and Mitochondrial Remodeling Following Ref-1 Inhibition i…

Verdict. We therefore sought to characterize proteome-wide signaling responses induced by second-generation Ref-1 redox inhibitor, APX2014. It intersects mitochondrial stress/dysfunction themes (functional impairment; OXPHOS / ETC; cancer).

What the authors report

Background Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ref-1/APE1) is a central regulator of redox-dependent transcriptional signaling that promotes pancreatic ductal adenocarcinoma (PDAC) progression, therapeutic resistance, and metabolic adaptation. While pharmacologic inhibition of Ref-1 suppresses tumor growth and alters cellular metabolism, immediate molecular events linking Ref-1 inhibition to downstream cellular adaptation remain poorly understood.

Key results stated in the abstract include the following. We therefore sought to characterize proteome-wide signaling responses induced by second-generation Ref-1 redox inhibitor, APX2014. Methods We applied an integrated multiplexed proteomics workflow to simultaneously quantify global protein abundance together with cysteine oxidation, phosphorylation, and lysine acetylation in Pa03C PDAC cells following acute treatment (30–120 min) with selective Ref-1 redox inhibitor APX2014. Results APX2014 induced rapid and extensive remodeling of PTM landscape while producing minimal changes in global protein abundance.

Why it matters for mitochondrial biology

Within mitochondrial research, this work maps primarily to OXPHOS, redox biology, metabolism, cancer. It is relevant to mitochondrial dysfunction discourse because the abstract invokes functional impairment, OXPHOS / ETC, cancer, systemic metabolic stress. That does not by itself establish a validated disease mechanism; it indicates thematic proximity. Because a therapeutic or interventional angle is present, the piece is of interest for mitochondrial-targeted drug hypothesis generation—subject to full-text validation of endpoints and safety context. OXPHOS/ETC involvement, if confirmed, would place the work in the core of bioenergetic pathophysiology rather than peripheral organelle biology. Server: biorxiv. Posted 2026-08-17. Synthesis confidence is bounded by abstract completeness.

Study design (abstract-level)

Differential post-translational modification (PTM) analysis, pathway enrichment, structural mapping of regulated sites, and functional mitochondrial substrate utilization assays were performed to define early signaling responses. Results APX2014 induced rapid and extensive remodeling of PTM landscape while producing minimal changes in global protein abundance. Functional mitochondrial assays confirmed impaired utilization of TCA cycle substrates following APX2014 treatment.

Principal findings

1. We therefore sought to characterize proteome-wide signaling responses induced by second-generation Ref-1 redox inhibitor, APX2014.
2. Methods We applied an integrated multiplexed proteomics workflow to simultaneously quantify global protein abundance together with cysteine oxidation, phosphorylation, and lysine acetylation in Pa03C PDAC cells following acute treatment (30–120 min) with selective Ref-1 redox inhibitor APX2014.
3. Results APX2014 induced rapid and extensive remodeling of PTM landscape while producing minimal changes in global protein abundance.
4. Functional mitochondrial assays confirmed impaired utilization of TCA cycle substrates following APX2014 treatment.
5. Our findings identify mitochondrial redox remodeling as an early consequence of Ref-1 inhibition, providing systems-level insight into how Ref-1-targeted therapies disrupt metabolic and stress-adaptive programs in pancreatic cancer.

Limitations of this brief

• This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
• Preprint status: findings may change with revision or journal review.
• Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
• Comparator/control language is weak or absent in the abstract, limiting causal inference from this brief alone.
• Primary source: biorxiv DOI 10.64898/2026.08.15.745014 (posted 2026-08-17).

Open scientific questions

• Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
• Are OXPHOS defects primary drivers or secondary consequences of broader cellular stress?
• What dose, timing, and off-target profile would be required to take the intervention seriously as a therapeutic hypothesis?
• How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?

Bottom line

For mitochondrial biologists focused on OXPHOS, redox biology, metabolism, this preprint is worth full-text review soon. Abstract-level takeaway: We therefore sought to characterize proteome-wide signaling responses induced by second-generation Ref-1 redox inhibitor, APX2014. Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.

Bibliographic record

Abstract-based editorial synthesis by Mitos. Not peer review.